NCT02337738 A Phase 2/3 Study of TVP-1012 at 0.5 mg or 1 mg in Levodopa Treated Parkinson's Disease Participants Status COMPLETED Phase PHASE2/PHASE3
NCT02337725 A Phase 3 Study of TVP-1012 (1 mg) in Early Parkinson's Disease Patients Status COMPLETED Phase PHASE3
NCT02334982 Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of TAK-137 in Healthy Participants Status COMPLETED Phase PHASE1
NCT02332824 A Phase 2 Dose-finding Study of TAK-272 in Participants With Type 2 Diabetes Mellitus and Microalbuminuria Status COMPLETED Phase PHASE2
NCT02324569 A Phase 4, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 4, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT02313155 Phase 1/2 Study of TAK-850 Subcutaneous Injection in Healthy Adults Status COMPLETED Phase PHASE1/PHASE2
NCT02312258 A Study of Oral Ixazomib Maintenance Therapy in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Not Treated With Stem Cell Transplantation (SCT) Status COMPLETED Phase PHASE3
NCT02302092 An Efficacy and Safety of Flomoxef Versus Cefepime in the Treatment of Participants With Urinary Tract Infections Status TERMINATED Phase PHASE3
NCT02302066 Safety and Immunogenicity of Different Schedules of Takeda's Tetravalent Dengue Vaccine Candidate (TDV) in Healthy Participants Status COMPLETED Phase PHASE2
NCT02285166 Specified Drug-use Survey of the Granular Capsule Formulation of Omega-3 Fatty Acid Ethyl Esters: OCEAN3 Status COMPLETED Phase N/A
NCT02284906 AD-4833/TOMM40_303 Extension Study of the Safety and Efficacy of Pioglitazone to Slow Cognitive Decline in Participants With Mild Cognitive Impairment Due to Alzheimer Disease Status TERMINATED Phase PHASE3
NCT02277691 A Phase III Long-term Study of TAK-536TCH in Participants With Essential Hypertension Status COMPLETED Phase PHASE3
NCT02276274 Effect of Food on the Pharmacokinetics of Single Oral Dose Administration of a Fixed-Dose Combination of SYR-322 and Metformin Hydrochloride in Healthy Adult Male Subjects Status COMPLETED Phase PHASE3
NCT02252354 TAK-385 Phase I Absorption, Distribution, Metabolism, Excretion and Absolute Bioavailability Study Status COMPLETED Phase PHASE1
NCT02231021 The Practical Evidence of Antidiabetic Combination Therapy in Korea Status COMPLETED Phase PHASE4
NCT02221284 Alogliptin Tablets Specified Drug-use Survey "Type 2 Diabetic Patients Receiving Combination Therapy With a Hypoglycemic Agent (e.g., Insulin Preparations or Rapid-acting Insulin Secretagogues)" Status COMPLETED Phase N/A